OM-RCA-01

N/A

Report date: 2026/01/21 20:00:47

Base Information

Drug NameOM-RCA-01
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionFibroblast growth factor receptors antagonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsMetastatic breast cancerProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesOncoMax Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKidney Cancer Research Bureau
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A